UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 288

Sortiert nach

NSAIDs Inhibit Tumorigenesis, but How?

Clinical cancer research, 2014-03, Vol.20 (5), p.1104-1113

2014

Volltextzugriff (PDF)

The path to the clinic: a comprehensive review on direct KRASG12C inhibitors

Journal of experimental & clinical cancer research, 2022-01, Vol.41 (1), p.1-27, Article 27

2022

Volltextzugriff (PDF)

The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment

Cancers, 2014-02, Vol.6 (1), p.436-458

2014

Volltextzugriff (PDF)

The RAS-Effector Interaction as a Drug Target

Cancer research (Chicago, Ill.), 2017-01, Vol.77 (2), p.221-226

2017

Volltextzugriff (PDF)

Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway

PloS one, 2011-12, Vol.6 (12), p.e29290-e29290

2011

Volltextzugriff (PDF)

Hypoxia-regulated microRNAs in human cancer

Acta pharmacologica Sinica, 2013-03, Vol.34 (3), p.336-341

2013

Volltextzugriff (PDF)

Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer

PloS one, 2014-06, Vol.9 (6), p.e98370

2014

Volltextzugriff (PDF)

COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs

Frontiers in oncology, 2013-01, Vol.3, p.181

2013

Volltextzugriff (PDF)

Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers

International journal of molecular sciences, 2019-12, Vol.21 (1), p.141

2019

Volltextzugriff (PDF)

Assessment of KRASG12C inhibitors for colorectal cancer

Frontiers in oncology, 2024-06, Vol.14, p.1412435

2024

Volltextzugriff (PDF)

Editorial: Targeting the Wnt/β-catenin signaling pathway in cancer

Frontiers in oncology, 2022-09, Vol.12, p.1022174-1022174

2022

Volltextzugriff (PDF)

New hydrazonoindolin-2-ones: Synthesis, exploration of the possible anti-proliferative mechanism of action and encapsulation into PLGA microspheres

PloS one, 2017-07, Vol.12 (7), p.e0181241-e0181241

2017

Volltextzugriff (PDF)

The interaction between the Wnt/β-catenin signaling cascade and PKG activation in cancer

Journal of biomedical research, 2017-01, Vol.31 (3), p.189-196

2017

Volltextzugriff (PDF)

Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agents

Journal of enzyme inhibition and medicinal chemistry, 2018-01, Vol.33 (1), p.867-878

2018

Volltextzugriff (PDF)

N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents

Cancers, 2024-06, Vol.16 (11), p.2033

2024

Volltextzugriff (PDF)

Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G

Molecular cancer therapeutics, 2009-12, Vol.8 (12), p.3331-3340

2009

Volltextzugriff (PDF)

Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer

Journal of experimental & clinical cancer research, 2019-08, Vol.38 (1), p.312-312, Article 312

2019

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors

Bioorganic & medicinal chemistry, 2009-08, Vol.17 (16), p.5974-5982

2009

Volltextzugriff (PDF)

Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics

PloS one, 2016-10, Vol.11 (10), p.e0163615-e0163615

2016

Volltextzugriff (PDF)

Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats

Cancers, 2023-01, Vol.15 (3), p.646

2023

Volltextzugriff (PDF)

Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy

Cancers, 2020-07, Vol.12 (8), p.2022

2020

Volltextzugriff (PDF)

Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer

Frontiers in pharmacology, 2021-12, Vol.12, p.736951-736951

2021

Volltextzugriff (PDF)

Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer

Journal of ovarian research, 2022-11, Vol.15 (1), p.120-17, Article 120

2022

Volltextzugriff (PDF)

MicroRNA and Cancer Chemoprevention

Cancer prevention research (Philadelphia, Pa.), 2013-05, Vol.6 (5), p.401-409

2013

Volltextzugriff (PDF)

Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS

MedComm (2020), 2020-09, Vol.1 (2), p.121-128

2020

Volltextzugriff (PDF)

1 – 25 von 288

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(255)

Publikationsform

Sprache

Englisch
(286)
Japanisch
(20)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(119)
Humans
(104)
Oncology
(55)
Pharmacology & Pharmacy
(40)
Animals
(39)
Antineoplastic Agents - Pharmacology
(34)
Cell Line, Tumor
(32)
Cell Proliferation - Drug Effects
(31)
Chemistry, Medicinal
(31)
Biological And Medical Sciences
(29)
Sulindac - Analogs & Derivatives
(27)
Medical Sciences
(26)
Cancer
(24)
Physical Sciences
(24)
Apoptosis - Drug Effects
(23)
Chemistry
(23)
Female
(23)
Structure-Activity Relationship
(23)
Apoptosis
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

NSAIDs Inhibit Tumorigenesis, but How?

The path to the clinic: a comprehensive review on direct KRASG12C inhibitors

The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment

The RAS-Effector Interaction as a Drug Target

Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway

Hypoxia-regulated microRNAs in human cancer

Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer

COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs

Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers

Assessment of KRASG12C inhibitors for colorectal cancer

Editorial: Targeting the Wnt/β-catenin signaling pathway in cancer

New hydrazonoindolin-2-ones: Synthesis, exploration of the possible anti-proliferative mechanism of action and encapsulation into PLGA microspheres

The interaction between the Wnt/β-catenin signaling cascade and PKG activation in cancer

Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agents

N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents

Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G

Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer

Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors

Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics

Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats

Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy

Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer

Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer

MicroRNA and Cancer Chemoprevention

Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS

Aktive Filter

Suchergebnisse filtern